Published in J Gen Virol on May 01, 1993
Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J Virol (1995) 5.01
Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage. J Virol (1998) 2.83
Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. J Virol (1997) 2.60
Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells. J Virol (2002) 2.44
Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades. J Virol (2002) 2.43
Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient. The Transfusion Safety Study Group. J Virol (1995) 2.15
Serotyping of primary human immunodeficiency virus type 1 isolates from diverse geographic locations by flow cytometry. J Virol (1995) 1.80
Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12. off. J Virol (1997) 1.66
Virus-induced immunosuppression: kinetic analysis of the selection of a mutation associated with viral persistence. J Virol (1994) 1.38
Antibody binding is a dominant determinant of the efficiency of human immunodeficiency virus type 1 neutralization. J Virol (2006) 1.23
Profile of resistance of human immunodeficiency virus to mannose-specific plant lectins. J Virol (2004) 1.17
Immune escape by human immunodeficiency virus type 1 from neutralizing antibodies: evidence for multiple pathways. J Virol (1993) 1.09
Primary virus envelope cross-reactivity of the broadening neutralizing antibody response during early chronic human immunodeficiency virus type 1 infection. J Virol (1999) 1.07
Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event. J Virol (2001) 1.04
Evidence for similar recognition of the conserved neutralization epitopes of human immunodeficiency virus type 1 envelope gp120 in humans and macaques. J Virol (2001) 1.02
Emergence of virus escape mutants after immunization with epitope vaccine. J Virol (1995) 1.01
Study of the dynamics of neutralization escape mutants in a chimpanzee naturally infected with the simian immunodeficiency virus SIVcpz-ant. J Virol (1997) 0.89
HIV antibodies for treatment of HIV infection. Immunol Rev (2017) 0.80
Characterization of circulating HIV type 1 env genes in plasma of two antiretroviral-naive slow progressing patients with broad neutralizing antibody response with evidence of recombination. AIDS Res Hum Retroviruses (2011) 0.79
Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group. Lancet (1998) 14.31
Climate change. Recent reductions in China's greenhouse gas emissions. Science (2001) 5.77
Climate forcing by anthropogenic aerosols. Science (1992) 5.67
Molecular genetic basis of the histo-blood group ABO system. Nature (1990) 4.17
Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J Exp Med (1986) 3.61
Glycosyltransferase activity of Fringe modulates Notch-Delta interactions. Nature (2000) 3.51
Amplification of surface temperature trends and variability in the tropical atmosphere. Science (2005) 2.99
Optimizing the exercise protocol for cardiopulmonary assessment. J Appl Physiol Respir Environ Exerc Physiol (1983) 2.76
Antibody response in primary human immunodeficiency virus infection. Lancet (1987) 2.69
Late presentation of HIV infection: a consensus definition. HIV Med (2011) 2.67
Subtype-specific problems with quantification of plasma HIV-1 RNA. AIDS (1997) 2.60
Predicted values for clinical exercise testing. Am Rev Respir Dis (1984) 2.58
Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group. JAMA (1994) 2.56
European guidelines on the clinical management of HIV-1 tropism testing. Lancet Infect Dis (2011) 2.47
The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group. N Engl J Med (1990) 2.46
Improved diagnosis of Pneumocystis carinii infection by polymerase chain reaction on induced sputum and blood. Lancet (1992) 2.40
Limited humoral immunity in hepatitis C virus infection. Gastroenterology (1999) 2.31
Autologous HIV-1 neutralizing antibodies: emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies. J Acquir Immune Defic Syndr (1992) 2.29
Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection. AIDS Res Hum Retroviruses (1991) 2.29
Loss of memory (CD27) B lymphocytes in HIV-1 infection. AIDS (2001) 2.28
Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation (2001) 2.28
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nat Med (1999) 2.27
HIV in pregnant women and their offspring: evidence for late transmission. Lancet (1991) 2.27
Carbon dioxide pressure-concentration relationship in arterial and mixed venous blood during exercise. J Appl Physiol (1985) (2001) 2.26
Neuritic transport of herpes simplex virus in rat sensory neurons in vitro. Effects of substances interacting with microtubular function and axonal flow [nocodazole, taxol and erythro-9-3-(2-hydroxynonyl)adenine]. J Gen Virol (1986) 2.24
Uptake and transport of herpes simplex virus in neurites of rat dorsal root ganglia cells in culture. J Gen Virol (1984) 2.22
New anti-HIV-1, antimalarial, and antifungal compounds from Terminalia bellerica. J Nat Prod (1997) 2.22
Software for a diffractometer with multiwire area detector. Methods Enzymol (1985) 2.20
Refractory coeliac disease in a country with a high prevalence of clinically-diagnosed coeliac disease. Aliment Pharmacol Ther (2014) 2.10
Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res (1999) 2.09
Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group. AIDS (2000) 2.08
Herpes simplex virus infection of the human sensory neuron. An electron microscopy study. Arch Virol (1988) 2.08
[Travelers' diarrhea]. Ugeskr Laeger (1993) 2.03
Diet and flight hypoxemia. Ann Intern Med (1989) 2.02
Effects of obesity on respiratory function. Am Rev Respir Dis (1983) 1.99
Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. J Virol (1987) 1.99
Effect of acetazolamide on acute mountain sickness. N Engl J Med (1968) 1.98
Asparagine-linked glycosylation of the scrapie and cellular prion proteins. Arch Biochem Biophys (1989) 1.96
Variation in human T lymphotropic virus III (HTLV-III) antibodies in homosexual men: decline before onset of illness related to acquired immune deficiency syndrome (AIDS). Br Med J (Clin Res Ed) (1985) 1.93
Full-length sequence of an ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C. AIDS Res Hum Retroviruses (1996) 1.92
Differential distribution of Australia-antigen-associated particles in patients with liver diseases and normal carriers. N Engl J Med (1973) 1.86
Localization of three human polypeptide GalNAc-transferases in HeLa cells suggests initiation of O-linked glycosylation throughout the Golgi apparatus. J Cell Sci (1998) 1.84
Gramicidin channel kinetics under tension. Biophys J (1998) 1.82
O-GLYCBASE version 4.0: a revised database of O-glycosylated proteins. Nucleic Acids Res (1999) 1.81
Prediction of O-glycosylation of mammalian proteins: specificity patterns of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase. Biochem J (1995) 1.81
Viral dynamics in primary HIV-1 infection. Karolinska Institutet Primary HIV Infection Study Group. AIDS (2000) 1.75
Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3. J Biol Chem (1997) 1.72
High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeks. Hepatology (1994) 1.71
Evidence for herpes simplex virus type-selective receptors on cellular plasma membranes. J Gen Virol (1979) 1.70
Detection of cytomegalovirus DNA in serum correlates with clinical cytomegalovirus retinitis in AIDS. J Infect Dis (1994) 1.69
Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer (1997) 1.69
Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients. AIDS Res Hum Retroviruses (1999) 1.69
Differential roles of B cells and IFN-gamma-secreting CD4(+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice. J Gen Virol (2001) 1.67
Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection. Br Med J (Clin Res Ed) (1987) 1.65
The recycling pathway of protein ERGIC-53 and dynamics of the ER-Golgi intermediate compartment. J Cell Sci (1998) 1.65
Isolation of human immunodeficiency virus (HIV) from plasma during primary HIV infection. J Med Virol (1987) 1.61
Purification and cDNA cloning of a human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase. J Biol Chem (1995) 1.60
Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis. N Engl J Med (1971) 1.60
Efficient isolation of HIV from plasma during different stages of HIV infection. J Med Virol (1988) 1.59
Severe acquired immunodeficiency in European homosexual men. Br Med J (Clin Res Ed) (1982) 1.59
Sorting by COP I-coated vesicles under interphase and mitotic conditions. J Cell Biol (1996) 1.58
Nosocomial HIV-transmission in an outpatient clinic detected by epidemiological and phylogenetic analyses. AIDS (1999) 1.58
A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS. Neurology (2002) 1.56
Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res (1988) 1.54
Differences in attachment between herpes simplex type 1 and type 2 viruses to neurons and glial cells. Infect Immun (1980) 1.53
O-glycosidic carbohydrate-peptide linkages of Herpes simplex virus glycoproteins. Arch Virol (1981) 1.53
Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection. J Acquir Immune Defic Syndr (1999) 1.53
Identification and characterization of large galactosyltransferase gene families: galactosyltransferases for all functions. Biochim Biophys Acta (1999) 1.52
Greenhouse Effects due to Man-Mad Perturbations of Trace Gases. Science (1976) 1.50
Binding of herpes simplex virus to cellular heparan sulphate, an initial step in the adsorption process. J Gen Virol (1991) 1.49
Unusual lectin-binding properties of a herpes simplex virus type 1-specific glycoprotein. J Virol (1981) 1.48
Liver-cell-membrane autoantibody specific for inflammatory liver diseases. Br Med J (1977) 1.48
Herpes simplex virus type-selective enzyme-linked immunosorbent assay with Helix pomatia lectin-purified antigens. J Clin Microbiol (1984) 1.48
Typing of clinical herpes simplex virus type 1 and type 2 isolates with monoclonal antibodies. J Clin Microbiol (1999) 1.48
The thyroid function and size in healthy man during 3 weeks treatment with beta-adrenoceptor-antagonists. Horm Metab Res (1991) 1.47
MUC5B and MUC7 are differentially expressed in mucous and serous cells of submucosal glands in human bronchial airways. Am J Respir Cell Mol Biol (1998) 1.47
cDNA cloning and expression of a novel human UDP-N-acetyl-alpha-D-galactosamine. Polypeptide N-acetylgalactosaminyltransferase, GalNAc-t3. J Biol Chem (1996) 1.46
Sonic hedgehog expression correlates with fundic gland differentiation in the adult gastrointestinal tract. Gut (2002) 1.46
Resistance to V3-directed neutralization caused by an N-linked oligosaccharide depends on the quaternary structure of the HIV-1 envelope oligomer. Virology (1996) 1.45
Cholesterol-induced protein sorting: an analysis of energetic feasibility. Biophys J (2003) 1.45
Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. Blood (2001) 1.44
A computerized word-processing and data system for histology in a private medical laboratory. Am J Clin Pathol (1979) 1.41
Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study Group. BMJ (1994) 1.41
Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection. AIDS (1999) 1.40
HIV-1 RNA is not detectable in the cerebrospinal fluid during antiretroviral combination therapy. AIDS (1997) 1.39
[Exposure to blood and risk of infection among health personnel]. Ugeskr Laeger (1993) 1.39
Cardiac output estimated noninvasively from oxygen uptake during exercise. J Appl Physiol (1985) (1997) 1.39